Clinical study
Chloroquine neuromyotoxicity. Clinical and pathologic perspective

https://doi.org/10.1016/0002-9343(87)90444-XGet rights and content

Abstract

Six cases of toxic myopathy and/or neuropathy with chloroquine and/or hydroxychloroquine therapy are described. Two patients had unique clinical and pathologic evidence of cardiomyopathy secondary to chloroquine or hydroxychloroquine therapy. One patient had polyneuropathy secondary to chloroquine toxicity. This may be the first documentation of several features of chloroquine/hydroxychloroquine toxicity: (1) morphologic changes in human peripheral nerve in chloroquine toxicity; (2) chloroquine/hydroxychloroquine cardiomyopathy diagnosed by endomyocardial biopsy; and (3) hydroxychloroquine myotoxicity. Chloroquine is a neuromyotoxin that affects nerves and cardiac and skeletal muscles. Discontinuation of chloroquine and hydroxychloroquine resulted in marked improvement in most cases. The reversibility of the symptoms emphasizes the importance of recognizing potential signs of nerve, muscle, and cardiac toxicity in patients being treated with chloroquine or hydroxychloroquine.

References (30)

  • HE Neville et al.

    Chloroquine-induced cytosomes with curvilinear profiles in muscle

    Muscle Nerve

    (1979)
  • JM Gerard et al.

    A morphologic study of neuromyopathy caused by prolonged chloroquine treatment

    Eur Neurol

    (1973)
  • ME Fedorko et al.

    Autophagic vacuoles produced in vitro—I. Studies in cultured macrophages exposed to chloroquine

    J Cell Biol

    (1968)
  • RD MacDonald et al.

    Experimental chloroquine myopathy

    J Neuropathol Exp Neurol

    (1970)
  • AG Engel

    Evolution and content of vacuoles in primary hypokalemic periodic paralysis

    Mayo Clin Proc

    (1970)
  • Cited by (0)

    View full text